Recombinant vesicular stomatitis vaccine against nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential
Thomas P. Monath, Richard Nichols, Lynda Tussey, Kelly Scappaticci, Thaddeus G. Pullano, Mary D. Whiteman, Nikos Vasilakis, Shannan L. Rossi, Rafael Kroon Campos, Sasha R. Azar, Heidi M. Spratt, Brent L. Seaton, W. Tad Archambault, Yanina V. Costecalde, Evan H. Moore, Roger J. Hawks, Joan Fusco
Dive into the research topics of 'Recombinant vesicular stomatitis vaccine against nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential'. Together they form a unique fingerprint.